Consolidated Statement of Income
| € millions |
See Note |
2020 |
2019 |
| Sales |
6 |
37,722.3 |
44,478.4 |
| Cost of sales |
|
-29,133.6 |
-33,893.4 |
| Gross margin on sales |
|
8,588.7 |
10,585.0 |
| Research and development expenses |
7 |
-4,330.6 |
-4,471.8 |
| Selling and logistics expenses |
|
-2,417.3 |
-2,718.9 |
| Administrative expenses |
|
-1,156.9 |
-1,110.2 |
| Other income |
8 |
1,711.2 |
1,774.6 |
| Other expenses |
8 |
-3,045.3 |
-4,203.2 |
| Income from equity-accounted investees |
10 |
-68.5 |
-124.3 |
| Other income from investments |
10 |
0.6 |
0.5 |
| EBIT |
|
-718.1 |
-268.3 |
| Interest income |
11 |
98.5 |
147.2 |
| Interest expense |
11 |
-282.2 |
-317.3 |
| Effects from currency translation |
11 |
-97.4 |
-30.5 |
| Effects from changes in the fair value of derivative instruments, and other valuation effects |
11 |
69.1 |
-119.7 |
| Financial result |
11 |
-212.0 |
-320.3 |
| Earnings before tax |
|
-930.1 |
-588.6 |
| Income tax expense |
12 |
11.3 |
-582.4 |
| Net income |
|
-918.8 |
-1,171.0 |
| Non-controlling interests |
|
-43.1 |
-54.0 |
| Net income attributable to the shareholders of the parent |
|
-961.9 |
-1,225.0 |
| |
|
|
|
| Basic earnings per share in € |
38 |
-4.81 |
-6.13 |
| Diluted earnings per share in € |
38 |
-4.81 |
-6.13 |
